爱婴室(603214) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 806,178,987.85, representing a year-on-year increase of 6.42%[5] - Net profit attributable to shareholders for Q1 2024 was CNY 6,306,934.32, a significant increase of 135.29% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 2,195,724.76, up 154.92% year-on-year[5] - The basic and diluted earnings per share for Q1 2024 were CNY 0.0449, an increase of 135.08% year-on-year[5] - The company reported a significant increase in investment income, reaching CNY 142.88 million, up 142.72% from the previous year[9] - Total operating revenue for Q1 2024 reached ¥806,178,987.85, an increase of 6.4% compared to ¥757,513,691.20 in Q1 2023[18] - Net profit for Q1 2024 was ¥6,913,884.63, compared to ¥6,114,499.83 in Q1 2023, representing an increase of 13.0%[19] - Earnings per share for Q1 2024 were ¥0.0449, up from ¥0.0191 in Q1 2023, indicating a growth of 134.0%[20] - The company reported a gross profit margin of approximately 94.9% for Q1 2024, compared to 97.1% in Q1 2023[29] Cash Flow and Investments - The net cash flow from operating activities decreased by 48.62% to CNY 81,000,045.25 compared to the previous year[5] - Cash inflow from operating activities in Q1 2024 was ¥897,126,081.05, down from ¥960,607,421.65 in Q1 2023, a decrease of 6.6%[22] - The company incurred a net cash outflow from investing activities of CNY 468,892,437.39, an improvement from CNY 535,977,131.16 in Q1 2023[23] - The financing activities generated a net cash inflow of CNY 6,072,564.85, a decrease of 90.6% from CNY 64,248,900.14 in the previous year[23] - The cash flow from operating activities showed a net outflow of ¥3,257,956.66, contrasting with a net inflow of ¥4,640,394.94 in Q1 2023[33] - Cash inflow from investment activities totaled ¥779,413,308.16, compared to ¥655,150,713.13 in the same period last year, marking an increase of 18.9%[33] - The cash outflow from investment activities was ¥1,059,670,844.63, up from ¥736,990,000.00 in Q1 2023, representing an increase of 43.8%[33] - The net cash flow from investment activities was -¥280,257,536.47, worsening from -¥81,839,286.87 in Q1 2023[33] Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 2,573,518,149.97, reflecting a 0.88% increase from the end of the previous year[6] - The equity attributable to shareholders decreased by 1.08% to CNY 1,125,909,266.38 compared to the end of the previous year[6] - The company's total assets amounted to RMB 2,573,518,149.97, an increase from RMB 2,551,051,886.00 as of December 31, 2023[14] - The company's current assets totaled RMB 1,723,784,471.47, compared to RMB 1,663,610,422.55 at the end of the previous year, reflecting a growth of approximately 3.2%[14] - Total liabilities increased to RMB 1,403,301,659.31 from RMB 1,369,155,888.49, marking an increase of approximately 2.5%[15] - Short-term borrowings rose to RMB 366,961,536.68 from RMB 295,453,859.67, reflecting an increase of about 24.1%[15] - The company's total equity decreased to CNY 631,142,892.63 from CNY 649,731,224.10 at the end of 2023, a decline of 2.8%[27] Shareholder Information - The company has a share repurchase account holding 1,450,000 shares, accounting for 1.03% of the total share capital[13] - The top ten shareholders hold a combined 69.77% of the company's shares, indicating a concentrated ownership structure[12] Other Financial Metrics - The weighted average return on equity increased by 0.31 percentage points to 0.55%[5] - The company experienced a 90.55% decrease in net cash flow from financing activities, totaling CNY 607,260.00, primarily due to share buybacks and fluctuations in short-term borrowing[9] - The company reported a decrease in sales expenses to ¥162,321,288.66 in Q1 2024 from ¥174,682,292.56 in Q1 2023, a reduction of 7.1%[18] - Other comprehensive income for Q1 2024 was ¥6,780.52, compared to a loss of ¥238,156.52 in Q1 2023, indicating a significant recovery[19] - The company’s research and development expenses were not disclosed in the report, indicating a potential area for future focus[29]